#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein associated polyneuropathy Anti-HLA antibody test positive Astrocytoma malignant Rhabdoid tumour Glycogen storage disease type II Cutaneous T-cell lymphoma stage I Piriformis syndrome Wiskott-Aldrich syndrome Castleman's disease Dedifferentiated liposarcoma Mucous membrane pemphigoid Inclusion body myositis Ocular myasthenia Autoimmune myositis Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Treatment Hepatoblastoma – Basic Information Optic glioma – Treatment Paroxysmal nocturnal haemoglobinuria – Diagnostics Breast angiosarcoma metastatic – Treatment Osteosarcoma – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency Acute respiratory distress syndrome Vascular malformation – Trials in Disease Bronchopulmonary dysplasia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Altizide Somatostatin Ecubectedin Riboflavin Bp Evx-01 Mifepristone Insulin Glargine Calcium Chloride Hexahydrate Exagamglogene Autotemcel IDP-121 Arsenic Trioxide Trimetazidine Dihydrochloride Samuraciclib SECRETIN SYNTHETIC HUMAN Dronedarone Exemestane Aaa802 Valsartan Vidutolimod Cx-044933 More therapies…

    Learn about Your Condition

    Bartonellosis Fontan procedure Acute kidney injury Oesophageal food impaction Lung adenocarcinoma stage IV Radius fracture Transitional cell carcinoma Mucosal inflammation Pulmonary embolism Tuberculosis Anaemia of pregnancy HER2 negative breast cancer Rosai-Dorfman syndrome Renal cancer recurrent Hypersomnia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ribocure Pharmaceuticals AB

Ribocure Pharmaceuticals AB

Vetenskapens Grand 11, Fassberg, Molndal, 431 53, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rbd5044 Sodium
    Poland Sweden
  • Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease

    Not yet recruiting

    2 1
    Poland Sweden
  • Study of RBD4059 and acetylsalicylic acid in patients with stable coronary artery disease: evaluation of safety and drug behavior in the body

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Rbd4059
    Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!